Marius Pharmaceuticals, LLC

RALEIGH, NC · Founded 2016 · CIK 0001777443 · Biotech · Private

Hormone-based pharmaceutical therapies for metabolic and endocrine conditions

mariuspharma.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$5.6M
2 Form D · Jun 2019
87 months since last filing
Contracts
—
No federal contracts on record
Patents
10
4 granted · 6 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$5,603,850
Private capital raisedForm D · SEC$20,000,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1809ImmunityBio, Inc.—$633M
1810MODERN MEADOW—$53M
1811Sapience Therapeutics Inc.—$8.3M
1812Marius Pharmaceuticals, LLC—$5.6M
1813MDI Therapeutics Investors, LLC——
1814Rectify——
1815Phylo——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 4 related persons
  • Om DhingraDirector · Executive Officer
  • Amit ShahDirector
  • Himanshu ShahDirector · Executive Officer
  • Shalin ShahExecutive Officer

Patents

USPTO · 4 granted of 10

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.